J Rheumatol. 1990 Jun;17(6):833-5.

CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.

Source

Rheumatology Section, Boston Veterans Administration Medical Center, MA.

Abstract

B lymphocytes which express the CD5 antigen on their cell surface have the ability to produce autoantibodies in vitro. We describe 2 patients, one with systemic lupus erythematosus and another with rheumatoid arthritis, whose percentages of peripheral blood CD5+ B lymphocytes were dramatically increased to 68 and 100%, respectively. A reduction of this subpopulation of B cells was associated with clinical improvement after therapy. This association suggests a relationship between CD5+ B cells and autoimmune disease activity.

PMID:: 1696993; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Case Reports

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Libraries

LinkOut Holdings

Supplemental Content

Save items

Related citations in PubMed

Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment. [In Vivo. 1994]
Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D, DeClerck LS, Bridts CH, Stevens WJ. In Vivo. 1994 Jul-Aug; 8(4):577-80.
Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity. [Clin Immunol Immunopathol. 1990]
Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity.
Becker H, Weber C, Storch S, Federlin K. Clin Immunol Immunopathol. 1990 Aug; 56(2):219-25.
Stimulatory effect of CD5 antibody on B cells from patients with rheumatoid arthritis. [Clin Immunol Immunopathol. 1988]
Stimulatory effect of CD5 antibody on B cells from patients with rheumatoid arthritis.
Hara M, Kitani A, Hirose T, Norioka K, Harigai M, Suzuki K, Tabata H, Kawakami M, Kawagoe M, Nakamura H. Clin Immunol Immunopathol. 1988 Nov; 49(2):223-30.
Review Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. [Annu Rev Immunol. 1989]
Review Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes.
Casali P, Notkins AL. Annu Rev Immunol. 1989; 7:513-35.
Review B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus. [Nat Clin Pract Rheumatol. 2006]
Review B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
Eisenberg R, Albert D. Nat Clin Pract Rheumatol. 2006 Jan; 2(1):20-7.

See reviews... See all...

Cited by 1 PubMed Central article

Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis. [Arthritis Res Ther. 2009]
Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis.
Lundy SK, Fox DA. Arthritis Res Ther. 2009; 11(4):R128. Epub 2009 Aug 25.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
J Rheumatol. 1990 Jun ;17(6):833-5.

PubMed
Myeloid dendritic cells in inclusion-body myositis and polymyositis.
Myeloid dendritic cells in inclusion-body myositis and polymyositis.
Muscle Nerve. 2007 Jan ;35(1):17-23.

PubMed
Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-...
Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity.
J Biol Chem. 1990 Aug 25 ;265(24):14497-504.

PubMed
Functionally defective high-density lipoprotein: a new therapeutic target at the...
Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
Pharmacol Rev. 2006 Sep ;58(3):342-74.

PubMed
Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogen...
Enhanced prostaglandin synthesis after ultraviolet injury is mediated by endogenous histamine stimulation. A mechanism for irradiation erythema.
J Clin Invest. 1990 Aug ;86(2):566-74.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: